Literature DB >> 8254023

Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. Reversibility and stimulus specificity of the deficits.

A M Powell1, R S Sherwin, G I Shulman.   

Abstract

To evaluate the roles of iatrogenic hypoglycemia and diabetes per se in the pathogenesis of defective hormonal counterregulation against hypoglycemia in insulin-dependent diabetes mellitus (IDDM), nondiabetic, and spontaneously diabetic BB/Wor rats were studied using a euglycemic/hypoglycemic clamp. In nondiabetic rats, recurrent (4 wk) insulin-induced hypoglycemia (mean daily glucose, MDG, 59 mg/dl) dramatically reduced glucagon and epinephrine responses by 84 and 94%, respectively, to a standardized glucose fall from 110 to 50 mg/dl. These deficits persisted for > 4 d after restoring normoglycemia, and were specific for hypoglycemia, with normal glucagon and epinephrine responses to arginine and hypovolemia, respectively. After 4 wk of normoglycemia, hormonal counterregulation increased, with the epinephrine, but not the glucagon response reaching control values. In diabetic BB rats (MDG 245 mg/dl with intermittent hypoglycemia), glucagon and epinephrine counterregulation were reduced by 86 and 90%, respectively. Chronic iatrogenic hypoglycemia (MDG 52 mg/dl) further suppressed counterregulation. Prospective elimination of hypoglycemia (MDG 432 mg/dl) improved, but did not normalize hormonal counterregulation. In diabetic rats, the glucagon defect appeared to be specific for hypoglycemia, whereas deficient epinephrine secretion also occurred during hypovolemia. We concluded that both recurrent hypoglycemia and the diabetic state independently lead to defective hormonal counterregulation. These data suggest that in IDDM iatrogenic hypoglycemia magnifies preexisting counterregulatory defects, thereby increasing the risk of severe hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8254023      PMCID: PMC288464          DOI: 10.1172/JCI116883

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  A high concentration of circulating insulin suppresses the glucagon response to hypoglycemia in normal man.

Authors:  D Liu; E Moberg; M Kollind; P E Lins; U Adamson
Journal:  J Clin Endocrinol Metab       Date:  1991-11       Impact factor: 5.958

Review 2.  Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM. A vicious cycle.

Authors:  P E Cryer
Journal:  Diabetes       Date:  1992-03       Impact factor: 9.461

3.  Diabetogenic action of streptozotocin: relationship of dose to metabolic response.

Authors:  A Junod; A E Lambert; W Stauffacher; A E Renold
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

4.  The spontaneously diabetic Wistar rat. Metabolic and morphologic studies.

Authors:  A F Nakhooda; A A Like; C I Chappel; F T Murray; E B Marliss
Journal:  Diabetes       Date:  1977-02       Impact factor: 9.461

5.  Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect.

Authors:  J E Gerich; M Langlois; C Noacco; J H Karam; P H Forsham
Journal:  Science       Date:  1973-10-12       Impact factor: 47.728

6.  Effects of acute insulin withdrawal and administration on plasma glucagon responses to intravenous arginine in insulin-dependent diabetic subjects.

Authors:  J E Gerich; M Lorenzi; E Tsalikian; N V Bohannon; V Schneider; J H Karam; P H Forsham
Journal:  Diabetes       Date:  1976-10       Impact factor: 9.461

7.  Counterregulatory adaptation to recurrent hypoglycemia in normal humans.

Authors:  M R Davis; H Shamoon
Journal:  J Clin Endocrinol Metab       Date:  1991-11       Impact factor: 5.958

Review 8.  Hypoglycemia unawareness.

Authors:  J E Gerich; M Mokan; T Veneman; M Korytkowski; A Mitrakou
Journal:  Endocr Rev       Date:  1991-11       Impact factor: 19.871

9.  Studies of pancreatic alpha cell function in normal and diabetic subjects.

Authors:  R H Unger; E Aguilar-Parada; W A Müller; A M Eisentraut
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

10.  Effects of differing insulin levels on response to equivalent hypoglycemia in conscious dogs.

Authors:  S N Davis; R Dobbins; C Tarumi; C Colburn; D Neal; A D Cherrington
Journal:  Am J Physiol       Date:  1992-10
View more
  33 in total

1.  Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans.

Authors:  S N Davis; C Shavers; F Costa; R Mosqueda-Garcia
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Orexin signaling is necessary for hypoglycemia-induced prevention of conditioned place preference.

Authors:  Oleg Otlivanchik; Nicole M Sanders; Ambrose Dunn-Meynell; Barry E Levin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-10-28       Impact factor: 3.619

3.  Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses.

Authors:  S N Davis; C Shavers; B Davis; F Costa
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

Review 4.  Hypoglycemia unawareness prevention: Targeting glucagon production.

Authors:  Willis K Samson; Lauren M Stein; Mollisa Elrick; Alison Salvatori; Grant Kolar; John A Corbett; Gina L C Yosten
Journal:  Physiol Behav       Date:  2016-04-11

5.  Excessive glucose production, rather than insulin resistance, accounts for hyperglycaemia in recent-onset streptozotocin-diabetic rats.

Authors:  R Burcelin; M Eddouks; J Maury; J Kande; R Assan; J Girard
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

6.  Counterregulatory deficits occur within 24 h of a single hypoglycemic episode in conscious, unrestrained, chronically cannulated mice.

Authors:  Lauren Jacobson; Tasneem Ansari; Owen P McGuinness
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-04       Impact factor: 4.310

7.  Brain insulin action regulates hypothalamic glucose sensing and the counterregulatory response to hypoglycemia.

Authors:  Kelly A Diggs-Andrews; Xuezhao Zhang; Zhentao Song; Dorit Daphna-Iken; Vanessa H Routh; Simon J Fisher
Journal:  Diabetes       Date:  2010-06-14       Impact factor: 9.461

8.  Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetes.

Authors:  X Fan; Y Ding; S Brown; L Zhou; M Shaw; M C Vella; H Cheng; E C McNay; R S Sherwin; R J McCrimmon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-04-08       Impact factor: 3.619

9.  Insulin signaling in alpha cells modulates glucagon secretion in vivo.

Authors:  Dan Kawamori; Amarnath J Kurpad; Jiang Hu; Chong Wee Liew; Judy L Shih; Eric L Ford; Pedro L Herrera; Kenneth S Polonsky; Owen P McGuinness; Rohit N Kulkarni
Journal:  Cell Metab       Date:  2009-04       Impact factor: 27.287

10.  Ventromedial hypothalamic nitric oxide production is necessary for hypoglycemia detection and counterregulation.

Authors:  Xavier Fioramonti; Nicolas Marsollier; Zhentao Song; Kurt A Fakira; Reema M Patel; Stacey Brown; Thibaut Duparc; Arnaldo Pica-Mendez; Nicole M Sanders; Claude Knauf; Philippe Valet; Rory J McCrimmon; Annie Beuve; Christophe Magnan; Vanessa H Routh
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.